Position in PRAX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,829,452
+$236,167 QoQ
Shares Held
32,347
-1.6% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#85
of 308 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. PRAX ranks #27 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in PRAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,829,452 | 32,347 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $10,593,285 | 32,879 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,348,215 | 28,324 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,420,082 | 26,794 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,149,689 | 27,341 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $920,013 | 24,294 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,752,302 | 22,769 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,330,094 | 23,116 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $917,861 | 22,192 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $9,275 | 152 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,386 | 152 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,907 | 2,285 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,138 | 3,599 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $51,260 | 63,363 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $131,971 | 55,450 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $125,274 | 55,187 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $118,736 | 48,464 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $422,448 | 41,376 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $746,807 | 37,909 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $658,946 | 35,638 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $531,399 | 29,070 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $346,895 | 10,589 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $554,876 | 10,085 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||